Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Supaglutide

A Study of the Efficacy and Safety of Supaglutide in Healthy Participants

Shanghai Yinnuo Pharmaceutical Technology Co. · Phase 1 · Completed · Enrollment 48

NCT03745885

ArmPopulationDoseWeeksEstimandWeight change
0.15mg Supaglutide or placeboT2D only0.15mgn/rn/rn/r
0.375mg Supaglutide or placeboT2D only0.375mgn/rn/rn/r
0.75mg Supaglutide or placeboT2D only0.75mgn/rn/rn/r
1.5mg Supaglutide or placeboT2D only1.5mgn/rn/rn/r
3.0mg Supaglutide or placeboT2D only3.0mgn/rn/rn/r